ROMIPLOSTIM N01
Clinical trials for ROMIPLOSTIM N01 explained in plain language.
Never miss a new study
Get alerted when new ROMIPLOSTIM N01 trials appear
Sign up with your email to follow new studies for ROMIPLOSTIM N01, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Hard-to-Treat blood disorder
Disease control Not yet recruitingThis study aims to test the safety and effectiveness of a medication called romiplostim in children with chronic immune thrombocytopenia (ITP), a condition where the body attacks its own platelets. It will involve 100 children aged 1-18 who have not responded well to standard fir…
Matched conditions: ROMIPLOSTIM N01
Sponsor: Assiut University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope to keep cancer treatment on track
Disease control Not yet recruitingThis study is testing if a drug called romiplostim N01 can help breast cancer patients recover their platelet counts after chemotherapy. Low platelets (thrombocytopenia) are a common side effect that can delay cancer treatment. The study will see if weekly injections of the drug …
Matched conditions: ROMIPLOSTIM N01
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC